HOUSE COMMERCE/OVERSIGHT SUBCOMMITTEE COUNSEL PATRICK McLAIN

Executive Summary

HOUSE COMMERCE/OVERSIGHT SUBCOMMITTEE COUNSEL PATRICK McLAIN is leaving Capitol Hill in February to become Senior VP of the Washington, D.C. management consultant firm Rowan & Blewitt. McLain served on the staff of Rep. Dingell's (D-Mich.) subcommittee for nearly 14 years. As subcommittee counsel, he was involved in several investigations related to the pharmaceutical industry, including oversight of FDA review of the AIDS products Virazole (by ICN subsidiary Viratek) and Imreg's Imreg-1. McLain also has been active in investigations of FDA's regulation of prescription drug advertising, health claims for food products, Rx-to-OTC switches, and the OTC Review.